Oncology Products

Description of Novion Pharma's Oncology Product Portfolio

Novion Pharma’s Oncology Product Portfolio features a diverse range of chemotherapy, targeted therapy, and supportive care medications, designed to meet the critical needs of cancer treatment. Our product line includes:

• Injectable Formulations – Liquid-based chemotherapy drugs such as Carboplatin, Cisplatin, Paclitaxel, and Doxorubicin, which are essential in treating solid tumors and hematological malignancies.
• Lyophilized (Freeze-Dried) Formulations – Stable, long-shelf-life injectables like Bendamustine, Bortezomib, Pemetrexed, and Zoledronic Acid, ensuring efficacy in cancer therapy.
• Oral Formulations – Targeted therapies and hormonal treatments such as Abiraterone, Anastrazole, Erlotinib, Capecitabine, and Lenalidomide, offering convenience and effectiveness in outpatient cancer management.

Our oncology medicines are manufactured under strict international quality standards (WHO-GMP, FDA, and EU compliance), ensuring high efficacy and patient safety. These treatments are used for breast cancer, lung cancer, leukemia, lymphoma, colorectal cancer, prostate cancer, and more.

Novion Pharma remains dedicated to expanding global access to innovative oncology therapies, providing cost-effective and high-quality cancer treatments to healthcare providers and patients worldwide.